Having trouble viewing this email? View in your browser.

25 September 2018

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


Call for ESCMID clinical guidance subcommittee members

ESCMID is currently looking to select six members who will form the first Guidelines Subcommittee (GLS). The GLS works with the Clinical Guidelines Director to implement ESCMID’s clinical guidelines (GL) programme.

Ideally, the composition of the GLS includes two infectious disease specialists, one infection control professional, two clinical microbiologists and one expert in GL development.

Interested candidates may look at the formal call for detailed information on eligibility.
 Qualified applicants are invited to send their CV and a cover letter (max. 2 pages) stating their motivation, qualifications, experience and publication record to ESCMID’s guidelines manager Nancy Gerits () before 30 September 2018.

For further information about the position before applying, please contact ESCMID’s Clinical Guidelines Director Luigia Scudeller (). 

› Read more

United Nations General Assembly High-level meeting on Tuberculosis – New York, 26 September 2018

ESCMID, and D Study Group for Mycobacterial Infections (ESGMYC) is supporting the UN High-level meeting on Tuberculosis, to be held tomorrow in New York City. You can watch the event live at UN WebTV here.

Other information about the meeting can be found on the meeting’s website here.

› Read more

Only two more weeks to nominate for TAE and Excellence Awards

Nominations are being accepted until 11 October 2018 at 12:00 noon CET for the Award for Excellence in recognition of an outstanding lifetime contribution to science, education or professional affairs in the field of infection as well as for the TAE Award for Training Achievements, which recognizes and rewards outstanding trainees in clinical microbiology and infectious diseases.

› Read more

CMI highlight: ESCMID Cross-sectional survey on antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli.

Representatives of all hospitals with more than 800 acute-care hospital beds in France, Greece, Israel, Italy, Kosovo, Slovenia, Spain and selected hospitals in the USA were contacted, with an overall response rate of 81.6%. Respondents were more likely to consider combination therapy when treating bacteraemia, pneumonia and central nervous system infections and for Enterobacteriaceae, P. aeruginosa and A. baumannii similarly.

› Read more

Open ESCMID position - Internship Abstract Handling (100%)

The intern supports the team in the planning and organization of ESCMID’s main annual congress and other events. He/she may be asked to help out with other office tasks, but will primarily support the congress team. The key task will be the handling of the abstract management and the support of abstract submitters. The internship starts preferably 1 November 2018 and lasts at least six months.You can find out more about the position here.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.